Improvement of Treatment Resistant Depression in a Patient With Primary Hypothyroidism and Thr92Ala5’ Type 2 Deiodinase Gene Polymorphism With Multiple Daily Doses of Triiodothyronine

Introduction: The augmentation pharmacologic therapy used in patients with treatment-resistant depression (TRD) includes drugs such as lithium, buspirone, triiodothyronine (LT3) and other drugs. We report a patient with TRD and primary hypothyroidism who responded to a combination of LT3, given in d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Ahmed, Ziyan, Sherin, Rinsha P V, Fonseca, Tatiana De Lourdes, Hoang, Thanh Duc, Shakir, Mohamed K M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Thyroid
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265896/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1915
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars